US Edition
Takeda Healthcare Airs sidePH Statement on Qdenga
3 Articles
3 Articles
Takeda Healthcare airs sidePH statement on Qdenga
MANILA, Philippines — Takeda Healthcare Philippines on Thursday said that its voluntary withdrawal of its dengue applications in the US and Singapore has something to do with requested data collection. Takeda, a Japanese pharmaceutical company, is the manufacturer of the dengue vaccine called Qdenga (TAK-003) and has already applied for a certificate of product registration (CPR) with the Food and Drug Authority (FDA). “The voluntary withdrawal…
Dengue vaccine maker awaiting Philippines approval
Japan-based Takeda Pharmaceuticals, manufacturer of the second-generation dengue vaccine Qdenga, said it is just waiting for approval of its product application following the completion of the requirements set by the Food and Drug Administration .
Cd. Madero, Tam. The municipal government of Ciudad Madero, in collaboration with the Health Court II, has reinforced measures to prevent the spread of dengue fever, given that the recent rains create an environment conducive to the proliferation of the mosquito transmitter. In this sense, public health brigades are carrying out interventions in areas where suspicious cases could be presented, with the aim of mitigating the risk of contagion amo…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
To view factuality data please Upgrade to Premium
